Additionally, recent studies have found that britannin upregulates the expression of GSK-3β and E-cadherin in a time-dependent manner, while downregulating the expression of p-GSK-3β, β-catenin, and N-Cadherin, thereby reducing the occurrence of EMT and significantly inhibiting HCC metastasis. The gene discussed is CDH2; the disease is hepatocellular carcinoma.